Heritable maintenance of chromatin modifications confers transcriptional memory of interferon-γ signaling.
Mikulski P. et al, (2025), Nat Struct Mol Biol
USP30 inhibition improves mitochondrial health through both PINK1-dependent and independent mechanisms
Williamson MG. et al, (2025)
CRISPRi: a way to integrate iPSC-derived neuronal models.
Franks SNJ. et al, (2024), Biochem Soc Trans, 52, 539 - 551
Correction: Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.
Hasan S. et al, (2023), Mol Neurodegener, 18
Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.
Hasan S. et al, (2023), Mol Neurodegener, 18
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.
Williamson MG. et al, (2023), Hum Mol Genet, 32, 2808 - 2821
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
Bogetofte H. et al, (2023), Cell Rep, 42
Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons.
Hasan S. et al, (2023), bioRxiv
Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function.
Carling PJ. et al, (2023), Autophagy, 19, 692 - 705
Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid.
Winchester L. et al, (2023), Brain Commun, 5
Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons
Hasan S. et al, (2023), JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 82, 541 - 541
Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
Okarmus J. et al, (2021), Stem Cell Reports, 16, 1510 - 1526
REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ. et al, (2021), J Neurosci, 41, 3731 - 3746
Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy.
Malpartida AB. et al, (2021), Trends Biochem Sci, 46, 329 - 343
Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.
Threlfell S. et al, (2021), Front Cell Neurosci, 15
Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
Okarmus J. et al, (2020), Sci Rep, 10
Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases.
Aman Y. et al, (2020), 155, 169 - 202